Prematurely Born Children: Vaccination – Safety and Specific Immune Response

The analysis of safety and efficiency of vaccination of the children born before the term (61 children of 1 – 4 degree of prematurity) and children born in time (21 children – group of comparison). For vaccination and revaccination was used: DTP (20 and 15 children respectively), DTaP (22 and 4 children), pentavalentny vaccine (DTaP/IPV/Hib – 9 and 2 children) and DT (10 children of the studied group with convulsion in the anamnesis). Against measles, mumps and a rubella was immunized 47 and 20 children respectively. After immunization all clinical symptoms was analyzed and after 2 months diphtheria measles and mumps antibodies was detected.

Prematurely born children has the 1 vaccination for 3 – 4 months later, then infants, with born at time. After vaccination 75.4% and 74.5% infants in both groups hadn’t any clinical symptoms. Acute respiratory infection was registered with the same frequency (25,5 – 25.0% and 24.6 – 23.8%). The antibodies titer to diphtheria, measles, mumps didn't depend on degree of prematurity. 

1. Guidelines № 3.3.1.1095-02 «Medical contraindications for preventive vaccination preparations of national immunization schedule (in Russian).

2. Immunization 2014 (reference). V.K.Tatochenko. NA Ozeretskovsky, A.M.Fedorov., Eds. 12 ed., Ext. Moscow; Pediatrician; 2014: 280 (in Russian).

3. Born too soon: the global action report on preterm birth, WHO Library Cataloguing-in-Publication Data, 2012. Available at: http://apps.who.int/iris/bitstre am/10665/44864/8/9789244503430_rus.pdf?ua=1&ua=1

4. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2011; 55.- RR-15.

5. Bernbaum J.C., Daft A., Anolik R. et al. Response of preterm infants to diphtheria-tetanus-pertussis immunizations. J. Pediatr, 1985; 107: 184 – 188.

6. Koblin B.A., Townsend T.R., Munoz A., Onorato I., Wilson M., Polk B.F. Response of preterm infants to diphtheria-tetanus-pertussis vaccine. Pediatr Infect Dis. J. 1988; 7 : 704 – 711.

7. Omenaca F., Garcia-Sicilia J., Garcia-Corbeira P., Boceta R., Romero A., Lopez G. et al. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue. Pediatrics 2005; 116: 1292 – 1298.

8. Shinefield H., Black S., Ray P., Fireman B., Schwalee M., Lewis E. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birthweight preterm infants. Ped. Inf. Dis. J. 2002; 21: 182 – 186.

9. Aaby P., Roth A., Ravn H., Napirna B.M., Rodrigues A., Lisse I.M. et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? JID. 2011; 204: 245 – 252. Available at: http://jid.oxfordjournals.org/.

10. Lyanka L.M. Clinical and immunological characteristics of DTP and measlesvaccination of children born to HIV-infected mothers St. Petersburg; Doctorate of med. sci. diss. 2006: 22 (in Russian).

11. Voronina O. Clinical and immunological characteristics of diseases post-vaccination period, and measures to prevent them. Saint Petersburg; Doctorate of med. sci. diss; 2007: 24 (in Russian).

12. Vaccine. Lecturesfor physicians. Ed.: Y. Lobzin. St. Petersburg: Ltd. Lithography; 2012: 285 (in Russian).